|
In an exchange filing on Sunday, Neogen Chemicals said, “The meeting of the board of directors of the Company is scheduled to be held on Wednesday, 8 December 2021 to consider, evaluate and approve the proposal for raising of funds by way of issue of any instrument including equity shares, fully/ partly convertible/ nonconvertible instruments including debenture warrants in one or more tranche including by way of a public issue, qualified institution placements, preferential issue or a private placement.”
Neogen Chemicals is chemical manufacturing company specialising in bromine based compounds, Grignard, Reagents and Inorganic Lithium Salts. On a consolidated basis, the company reported a 51.4% increase in net profit to Rs 11.17 crore on a 38.1% rise in net sales to Rs 113.18 crore in Q2 FY22 over Q2 FY21.
Shares of Neogen Chemicals were trading 4.13% lower at Rs 1,691.40 on BSE.
|